Helmut Albrecht to Drug Therapy, Combination
This is a "connection" page, showing publications Helmut Albrecht has written about Drug Therapy, Combination.
Connection Strength
0.337
-
Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
Score: 0.134
-
Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia. Ann Pharmacother. 2011 Jul; 45(7-8):967-76.
Score: 0.088
-
Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. ALTAIR--the end of NRTI-only regimes. J Watch AIDS Clin Care. 2009 Oct; 21(10):82.
Score: 0.077
-
Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet HIV. 2019 06; 6(6):e364-e372.
Score: 0.038